Aclaris Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference

Rhea-AI Summary

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced its participation in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference on March 30, 2023, at 1:00 PM ET. Members of the management team will engage in a fireside chat, which can be accessed via the 'Events' page on Aclaris' website. The webcast will be archived for at least 30 days. Aclaris focuses on developing novel drug candidates for patients with immuno-inflammatory diseases and boasts a multi-stage portfolio powered by a strong R&D engine, addressing significant treatment gaps in this area.

WAYNE, Pa., March 27, 2023 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference on Thursday, March 30, 2023 at 1:00 PM ET.

A webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Therapeutics Contact:

Robert A. Doody Jr.
Vice President, Investor Relations
484-639-7235
rdoody@aclaristx.com

FAQ

When is Aclaris Therapeutics participating in the virtual conference?

Aclaris Therapeutics will participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference on March 30, 2023, at 1:00 PM ET.

How can I access the Aclaris Therapeutics fireside chat?

The fireside chat can be accessed through the 'Events' page in the 'Investors' section of Aclaris' website.

Will the Aclaris Therapeutics conference webcast be available later?

Yes, the webcast of the Aclaris fireside chat will be archived for at least 30 days on their website.

What is the focus of Aclaris Therapeutics?

Aclaris Therapeutics is focused on developing novel drug candidates for immuno-inflammatory diseases.

What is the stock symbol for Aclaris Therapeutics?

The stock symbol for Aclaris Therapeutics is ACRS.